TABLE I.
All subjects (n = 264) | Caucasians (n = 162) | African–Americans (n = 102) | |||||||
---|---|---|---|---|---|---|---|---|---|
n | Mean ± SE | p value | n | Mean ± SE | p value | n | Mean ± SE | p value | |
Age at prostatectomy | |||||||||
<60 | 114 | 0.105 ± 0.003 | 0.91 | 66 | 0.105 ± 0.003 | 0.36 | 48 | 0.103 ± 0.004 | 0.34 |
60+ | 150 | 0.104 ± 0.002 | 96 | 0.102 ± 0.003 | 54 | 0.109 ± 0.004 | |||
PSA at diagnosis | |||||||||
Low (<4 ng/mL) | 45 | 0.105 ± 0.004 | 0.88 | 34 | 0.106 ± 0.004 | 0.38 | 11 | 0.104 ± 0.008 | 0.53 |
Moderate (4–10 ng/mL) | 176 | 0.105 ± 0.002 | 98 | 0.104 ± 0.003 | 78 | 0.105 ± 0.003 | |||
High (>10 ng/mL) | 43 | 0.103 ± 0.004 | 30 | 0.097 ± 0.005 | 13 | 0.114 ± 0.008 | |||
Tumor volume | |||||||||
Low (<20% of gland) | 136 | 0.110 ± 0.002 | 0.0006 | 82 | 0.109 ± 0.003 | 0.003 | 54 | 0.111 ± 0.004 | 0.07 |
High (≥20% of gland) | 128 | 0.099 ± 0.002 | 80 | 0.097 ± 0.003 | 48 | 0.101 ± 0.004 | |||
Prostate volume | |||||||||
Low (< 65 cc) | 133 | 0.108 ± 0.002 | 0.02 | 78 | 0.105 ± 0.003 | 0.35 | 55 | 0.112 ± 0.004 | 0.02 |
High (≥65 cc) | 131 | 0.101 ± 0.002 | 84 | 0.101 ± 0.003 | 47 | 0.099 ± 0.004 | |||
Tumor stage | |||||||||
2 | 204 | 0.105 ± 0.002 | 0.54 | 125 | 0.103 ± 0.003 | 0.76 | 79 | 0.107 ± 0.003 | 0.56 |
3 or 4 | 60 | 0.103 ± 0.003 | 37 | 0.102 ± 0.004 | 23 | 0.103 ± 0.004 | |||
Advanced Gleason Grade1 | |||||||||
No | 200 | 0.103 ± 0.002 | 0.31 | 122 | 0.103 ± 0.002 | 0.97 | 78 | 0.104 ± 0.004 | 0.10 |
Yes | 64 | 0.107 ± 0.003 | 40 | 0.103 ± 0.004 | 24 | 0.114 ± 0.006 |
No = Gleason sum 6 or less or Gleason sum 7 and primary Gleason grade 3 or lower; Yes = Gleason sum 8 or higher or Gleason sum 7 and primary Gleason grade 4 or higher.